Lung Cancer Diagnostics Market is estimated to grow at a CAGR of 7.3% during the forecast period of 2023-2030 : Cognitive Market Research

Market Overview:
- Lung cancer starts in the lungs and it can spread to lymph nodes or other organs in the body, such as the brain. Cancer from other organs can also spread to the lungs. When cancer cells spread from one body organ to another, they are called metastases. Lung cancers are grouped into two main types: small cells and non-small cells. Non-small cell lung cancer is most common than small cell lung cancer.

Summary:
- The global lung cancer diagnostics market was valued at 3.12 billion in 2022 and is projected to expand at a CAGR of 7.3% between 2023 and 2030. The rising prevalence of lung cancer globally, the growing rate of smokers, and increasing pollution are the major driving factors for the growth of the lung cancer diagnostics market.

"To know more The Lung Cancer Diagnostics Market statistics click here: https://www.cognitivemarketresearch.com/lung-cancer-diagnostics-market-report

Market Dynamics
- Rising prevalence of lung cancer across the globe, growing rate of smokers, and increasing air pollution are some of the major driving factors for the growth of the lung cancer diagnostics market. Increasing cases of lung cancer across both developed and developing countries are augmenting the growth of the market. Lung cancer is the second most common cancer in both men and women. According to the American Cancer Society's estimates, there will be about 238,340 new cases of lung cancer (117,550 in men and 120,790 in women) in 2023, in the United States.
Further, the surge in the adoption of accurate and effective diagnostic testing for cancer is likely to drive the market in the near future. However, high diagnostics costs and a lack of awareness about diseases can hamper the growth of the market.

Market Segmentation:
Diagnostic Test
• Imaging Tests
• Pulmonary Function Tests
• Lung Tissue Analysis
• Others

Cancer Type
• Non-small Cell Lung Cancer (NSCLC)
• Small Cell Lung Cancer (SCLC)
Non-small Cell Lung Cancer (NSCLC) segment is generating the highest revenue across the globe, due to the growing number of this type of cancer cases, and increasing awareness about lung cancer diagnostics. According to the American Cancer Society, 84% of lung cancers are Non-small Cell Lung Cancer (NSCLC).

End-User
• Hospitals
• Clinics
• Diagnostic Centers

The Major Players in Lung Cancer Diagnostics Market are:
Roche Diagnostics, BioMérieux, Qiagen, Advpharma, AIT Austrian Institute of Technology, Courtagen Life Sciences, DiagnoCure, BioMark Diagnostics, Mayo Clinic, HalioDx SAS

Get free sample pages of latest published Lung Cancer Diagnostics Report:
https://www.cognitivemarketresearch.com/lung-cancer-diagnostics-market-report#request_sample

News
- Roche improved the speed and accuracy of non-small cell lung cancer diagnosis with the launch of an automated digital pathology algorithm (July 2020)
Roche announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer. The system offers pathologists automated evaluations of scanned slide pictures that are reproducible and objective, and which have the potential to help with patient diagnosis and, eventually, focused therapy options.

Regional Analysis:
- North American region dominates the market, owing to the strong implantation of diagnostics programs, adoption of technologically advanced solutions, and strong healthcare infrastructure in this region. On the other hand, Europe is estimated as the second largest market for the global lung cancer diagnostics market. This is due to the rising cases of lung cancer patients, and the increasing smoking population.

Browse here for Full TOC:
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
Chapter 1 Industrial Insight and Market Scope
• 1.1 Global Lung Cancer Diagnostics Industry Introduction
• 1.2 Objectives of the Study
• 1.3 USP of the Report
• 1.4 Who is this report for?
• 1.5 Designing of Market Scope
1.5.1 Lung Cancer Diagnostics Market Segmentation
1.5.1 Lung Cancer Diagnostics Market Regional Fragmentation
1.5.1 Lung Cancer Diagnostics Market Players
• 1.6 Report Duration
Chapter 2 Research Methodology Review Complete Research Methodology
Chapter 3 Executive Summary of Lung Cancer Diagnostics Market
Chapter 4 Global Lung Cancer Diagnostics Market Overview
Chapter 5 Competitive Analysis (Subject to Availability)
Chapter 6 Qualitative Analysis
Chapter 7 Company Profiling (Subject to Availability)
Chapter 8 Global Lung Cancer Diagnostics Market by Diagnostic Test Segmentation Analysis (2018-2030)
Chapter 9 Global Lung Cancer Diagnostics Market by End-User Segmentation Analysis (2018-2030)
Chapter 10 Global Lung Cancer Diagnostics Market by Cancer Type Segmentation Analysis (2018-2030)
Chapter 11 Global Lung Cancer Diagnostics Market Regional Analysis
Chapter 12 North America Lung Cancer Diagnostics Market Outlook (2018 - 2030)
Chapter 13 Europe Lung Cancer Diagnostics Market Outlook (2018 - 2030)
Chapter 14 Asia Pacific Lung Cancer Diagnostics Market Outlook (2018 - 2030)
Chapter 15 Latin America Lung Cancer Diagnostics Market Outlook (2018 - 2030)
Chapter 16 Middle East and Africa Lung Cancer Diagnostics Market Outlook (2018 - 2030)
Chapter 17 Research Findings
• 17.1 Key Takeaways
• 17.2 Analyst Point of View

To know more Lung Cancer Diagnostics Market TOC click here: https://www.cognitivemarketresearch.com/lung-cancer-diagnostics-market-report#table_of_contents

Related Reports
• Cancer Diagnostics Market - https://www.cognitivemarketresearch.com/cancer-diagnostics-market-report
• Breast Cancer Diagnostics Market - https://www.cognitivemarketresearch.com/breast-cancer-diagnostic-market-report
• HIV Diagnostics Market - https://www.cognitivemarketresearch.com/hiv-diagnostics-market-report

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us

About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.

This release was published on openPR.